GenScript Invented 7-minute eStain Protein Staining System

May 10, 2010 - PRLog -- PISCATAWAY, N.J., May 10, 2010-Internationally recognized biology contract research organization GenScript USA Inc. has invented a revolutionary protein gel staining device. It takes 7 minutes or less with no loss in detection sensitivity to complete the staining and destaining processes of SDS-PAGE using Coomassie blue, which usually takes 2–3 hours for staining and overnight for destaining.

http://www.genscript.com/estain_protein_staining_system.html
http://www.genscript.com

SDS-PAGE and gel staining are the most common techniques used in proteomics research. The staining and destaining processes involved usually take many long hours to complete. GenScirpt’s 7-minute eStainTM Protein Staining System is built based on the electric staining concept. An electric field generated between the cathode and anode in the device is used in both gel staining and de-staining processes. “It only takes 7 minutes to get the job done,” said John Wang, VP of Bio-Reagent Division. “I am sure that with this invention, there will be a whole lot more happy researches out there from now on.”

GenScript is a contract research organization (CRO) specialized in biological research and drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. The renowned one-stop bioreagent services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development. Headquartered in Piscataway, New Jersey, GenScript has become a world-leading Biology CRO and the largest gene synthesis supplier in the USA, with subsidiaries in France, Japan, and China.


For further information, please contact:
Sally Wang
Executive Vice President
GENSCRIPT USA Inc.
1-(732) 885-9188

# # #

GenScript is a contract research organization (CRO) specialized in biological research and drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development.